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ABSTRACT 
 
 
 
Through the use of in vitro methods, previous research in animal models has 
attempted to isolate the effects of local metabolic factors, normally associated with 
exercising skeletal muscle, on vascular reactivity and thus blood flow regulation. 
Utilizing an in vitro vessel approach and human skeletal muscle feed arteries, the purpose 
of these studies was to determine if local factors, such as heat and acidosis, could alter 
vascular reactivity and thus contribute to reduced sympathetically induced 
vasoconstriction (functional sympatholysis) and exercise hyperemia. Specifically, it was 
hypothesized that heat and acidosis will suppress vasocontracile function in human 
skeletal muscle feed arteries. The first study investigated the effect of temperature on α1-
adrenergic receptor stimulation using phenylephrine (PE). Cooling to 35 °C or heating to 
39 °C both resulted in an attenuated PE-induced vasocontraction, while smooth muscle 
function, as determined by KCl, remained unchanged. The goal of the second study was 
to determine if the potent vasodilator, nitric oxide (NO), could be a factor mediating the 
heat-induced attenuation in PE-induced contraction observed in the first study.  Heating 
again reduced PE-induced vasocontraction, and was restored with NO blockade. Using 
molecular approaches, it was determined that heating did not change the density of α1-
receptors, but increased endothelial nitric oxide synthase (eNOS) protein expression. The 
third study sought to determine the effect of acidosis on vascular reactivity. Increasing 
levels of acidosis resulted in graded reductions in α1- receptor-induced vasocontraction, 
which was in part due to reduced smooth muscle function as assessed by KCl. Increasing 
acidosis maintained maximal vasorelaxation and suggested enhanced sensitivity to both 
the endothelium-dependent agonist acetylcholine (ACh) and the endothelium-
independent NO donor sodium nitroprusside (SNP). Collectively, these results indicate 
that local factors normally associated with exercise-induced increases in skeletal muscle 
metabolism (i.e. heat and acidosis) are, in fact, capable of altering feed artery vascular 
reactivity in humans, and therefore likely play a role in sympatholysis in vivo.   
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BACKGROUND 
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Energy production for movement and exercise relies heavily upon the delivery of 
reactants for metabolism such as oxygen, nutrients, as well as the removal of metabolic 
by-products from the active skeletal muscle. Blood flow is a key variable governing both 
the delivery of metabolic reactants and removal of waste. Thus, the ability to exercise is 
dependent upon the capacity to increase or maintain skeletal muscle blood flow as 
dictated by a given level of muscular activity and requisite metabolic rate. 
It is well known that heart rate, blood pressure, cardiac output, blood flow, and 
oxygen consumption increase linearly with graded exercise from rest towards maximal 
effort (1, 27). The purpose of this dynamic cardiovascular response is to increase blood 
flow and delivery of oxygen and nutrients but also to remove accumulating metabolic by-
products associated with muscular work such as heat, hydrogen ions, and carbon dioxide 
(27). In the face of the increased demand for skeletal muscle perfusion, a finite blood 
volume must be redistributed to maintain adequate blood pressure; failure to do so would 
result in decrement in exercise performance and more importantly, a loss of 
consciousness (40, 41). 
At the onset of exercise, there is a global sympathetic activation, known as the 
exercise pressor reflex (2, 8, 41). The exercise pressor reflex is characterized by a global 
vasoconstriction prior to and at the onset of exercise (44). However, shortly thereafter, 
blood flow toward active muscle beds increases dramatically, despite systemic 
sympathetically induced vasoconstriction (46). This functional hyperemia has been 
attributed to many different mechanisms, such as the effect of local metabolites on 
vascular smooth muscle contraction, an alteration in the response to vasoconstrictor 
substances, or the mechanical effects of muscle contraction (19, 28, 41, 46). 
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The acute regulation of vascular smooth muscle tone and mean arterial pressure is 
largely achieved through sympathetically mediated adrenergic tone. Thus, the functional 
hyperemia at the onset of exercise, despite a significant sympathetic activation, is 
generally referred to as “functional sympatholysis,” originally recognized by 
Remensynder et al. in 1962 (34). The term sympatholysis was coined based upon the 
original concept that during the initial phase of exercise, sympathetic tone was being 
“lysed” to allow increased blood flow to the now highly metabolically active muscle 
compartment. 
One of the purported factors involved in sympatholysis is an elevation in local 
temperature, a consequence of increased metabolic demand (15). Previous research has 
provided evidence that intramuscular temperature can increase significantly at the onset 
of, and throughout, an acute exercise bout (12, 26). Cui et al. (5) found that passive 
heating reduced mean vascular responsiveness to the systemic administration of the α1-
adrenergic agonist phenylephrine (PE). However, this study lacked the specificity to 
determine if increased temperature can exhibit a sympatholytic effect in arteries feeding 
skeletal muscle, as the drug was administered systemically and its consequences were 
measured via mean arterial pressure (5). Thus, the findings by Cui et al. (5) cannot truly 
be applied to the skeletal muscle vasculature, and the question if temperature could be a 
mechanism contributing to functional sympatholysis remains unanswered.   
Functional sympatholysis during exercise appears to depend on a functional 
endothelium (10), suggesting a potential link between sympatholysis and nitric oxide 
(NO) (3). Indeed, Harris et al. (13) found that heat exposure significantly reduced the 
vasoconstrictory effects of PE in rat aortic rings, and this effect was abolished with NO 
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blockade. These findings implicate NO as a component of the sympatholytic effect of 
temperature, perhaps by offering increased endogenous opposition to vasoconstrictors. 
However, these findings have yet to be confirmed in human arteries. 
Another local factor associated with skeletal muscle metabolism is increased 
hydrogen ion (H+) production and subsequent reductions in pH. In 1880, Gaskell (11) 
originally proposed the hypothesis that lactate and the associated hydrogen ions exert a 
profound effect upon the vasculature. Not until the 1960s did another research group 
follow up on Gaskells’ hypothesis. Specifically, Kontos and colleagues (6, 7, 22) 
performed an elegant series of in vivo experiments originally designed to understand the 
role of hypoxia and hypercapnia on hemodynamics. They determined that hypercapnia 
and the associated acidosis was a major stimulus for vasodilation (21, 23-25); however, it 
was unknown how acidosis induced this hyperemic response. Subsequent in vitro 
experiments have confirmed these findings indicating a vasodilatory effect of acidosis at 
baseline (9, 14, 17, 18, 29, 33), and in response to various agonists (4, 16, 20, 30, 31, 37, 
42) in the animal model, although not all agree acidosis is vasodilatory (35, 36, 38). 
Only one study, to date, has used human arteries to determine the effect of 
acidosis on vascular reactivity. Rohra et al. (39) obtained internal mammary arteries from 
coronary bypass graft surgery and studied them in vitro using isometric tension 
technique. This study determined that acidosis elicited a vasorelaxation from pre-
contraction with PE or endothelin-1 (39). However, the question remains whether 
acidosis, such as that achieved during exercise, can alter the vascular reactivity in arteries 
that are capable of regulating skeletal muscle blood flow, such as the feed artery (43, 47). 
Most of the aforementioned studies have used cerebral (9, 21, 29, 31, 33), pulmonary (16, 
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31), coronary (14, 17, 18), mesenteric (42), or conduit level arteries (4, 20); only Faber 
and colleagues have studied the effect of acidosis on microvascular or resistance arteries 
in the skeletal muscle vasculature (30, 45). While these experiments were elegantly and 
carefully performed, the results from the cremaster muscle model used by Faber may not 
be applicable to locomotor muscles.  
Recent work by Moore and colleagues (32) has provided evidence that challenges 
the classic dogma that proximal regulation of blood flow (e.g. feed artery) is controlled 
by α1-adrenergic receptors and distal regulation (e.g. terminal arterioles) is primarily 
controlled by α2-adrenergic receptors, such that only the α2- receptors should be 
suppressed by metabolic inhibition. In fact, Moore et al. (32) determined that adrenergic 
receptor function is rather heterogeneous in progression from larger arteries to the 
terminal arterioles. Thus, the effect of local factors (e.g. acidosis or heating) upon the 
potent α1-adrenergic receptors in human skeletal muscle feed arteries remains unknown.          
Accordingly, the purpose of this dissertation will be to determine the effect of 
temperature on α1-adrenergic-mediated vasocontraction and the potential role for NO in 
mediating this temperature-induced sympatholysis. Additionally, we sought to determine 
the potential for local reductions in pH to reduce smooth muscle and α1-adrenergic 
mediated vasocontraction. The first study will determine, in vitro, if temperature exerts a 
sympatholytic effect on the α1-adrenergic receptor. The second study will determine, in 
vitro, the role of NO in mediating the sympatholytic effect of temperature on the α1-
adrenergic receptor. The third study will determine, in vitro, the effect of local reductions 
in pH on α1-adrenergic mediated vasocontraction.  Overall, these studies will provide 
insight into the role of local factors in functional sympatholysis. 
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Abstract 
 
Heat and cold exposure can decrease and increase total peripheral resistance, 
respectively, in humans. With unique access to human skeletal muscle feed arteries, we 
sought to both characterize these vessels and to determine the interaction between 
temperature and α1-adrenergic receptor responsiveness. We hypothesized that α1-
mediated vasocontraction of human feed arteries would be attenuated in response to 39 or 
35˚C. Skeletal muscle feed arteries were harvested from thirty-two human volunteers and 
studied using isometric techniques. Vessel function was assessed using potassium 
chloride (KCl), sodium nitroprusside (SNP), phenylephrine (PE), and acetylcholine 
(ACh) dose-response curves (DRCs) to characterize non-receptor- and receptor-mediated 
vasocontraction and vasorelaxation. Single doses of PE (1mM) and KCl (100mM) were 
administered at 37˚C and then, in a balanced design, repeated at both 35˚ and 39˚C. The 
KCl and PE DRCs elicited significant vasocontraction (2009±407; 1974±508 developed 
tension (mg), respectively), whereas SNP and ACh induced the expected vasorelaxation 
(102±6; 73±10 % relaxation, respectively). Altering temperature had no effect on 
inherent smooth muscle function (KCl response), but both a reduction (35˚C) and an 
increase (39˚C) in temperature decreased the vasocontractile response to 1mM PE (37˚C: 
1478 ± 338, 35˚C: 546 ± 104, and 39˚C: 896 ± 202 mg; p<0.05), or across PE dose 
(p<0.05; 35 and 39˚C vs. 37˚C). Despite clear heterogeneity between both the human 
volunteers and the feed arteries themselves, this novel approach to the procurement of 
human vessels revealed a robust “inverted U” response to altered temperature, such that 
α1-mediated vasocontraction was attenuated with either warming or cooling.  
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Introduction 
 
In rodent skeletal muscle, it has been established that a primary control point for 
regulating total muscle blood flow during exercise is the feed artery (33, 39). Human 
skeletal muscle feed arteries, while relatively large compared to the equivalent vessels in 
rodents, are by human standards very small (1-2% of aortic diameter), and have a similar 
anatomical location. Therefore, human feed arteries also likely contribute significantly to 
blood flow regulation by varying vascular resistance prior to entry into the muscle bed. 
Although difficult to obtain, human skeletal muscle feed arteries can, in fact, be harvested 
during certain surgical procedures and studied in vitro. However, not only are the 
vasocontraction and vasorelaxation characteristics of human feed arteries not well 
characterized, the impact of temperature upon vasoconstrictor agents important in the 
regulation of muscle blood flow in response to stress, such as norepinephrine, is 
unknown.  
The specific effect of temperature on vasoconstrictor responsiveness has been 
extensively studied in vitro in vessels from animals. However, potentially, at least in part, 
due to methodological differences, the results have been equivocal, with alterations in 
temperature leading to an increase (23, 28), a decrease (8, 17, 24, 26, 31, 37), or no 
change (16, 22, 34) in α-adrenergic mediated vasoconstriction. While there are no human 
in vitro studies with which to compare, prior in vivo animal and human studies on this 
topic reveal a general reduction in α-adrenergic vascular reactivity during local heating 
(40) or systemic increases in core temperature (2, 18, 25, 40). However, recent work 
performed by Keller et al. (15) suggested that adrenergic responsiveness is maintained 
during heat stress localized to the leg. Such in vivo measurements represent the 
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summation of the net vascular response and thus with such an approach it is currently not 
possible to differentiate the contribution of various levels of the arterial tree. An in vitro 
assessment of temperature and adrenergic responsiveness in human vessels recognized to 
regulate blood flow could provide greater clarity to this issue. 
Thus, with the novel approach of harvesting human skeletal muscle feed arteries 
and an interest in α1-receptor responsiveness in humans, utilizing an isolated in vitro 
model, we sought to a) assess the vasocontraction and vasorelaxation characteristics of 
these human feed arteries and b) determine if changes in temperature exert an effect on 
the α1-adrenergic receptor responsiveness of these human feed arteries. Specifically, with 
implications for blood flow regulation in the face of both heating and cooling, we 
hypothesized that both an increase or a decrease in temperature from 37˚C would 
attenuate the vasocontractile response to the α1-agonist phenylephrine. 
 
Methods 
Subjects and General Procedures 
A heterogeneous group of 32 subjects (20 males and 12 females, 37-93 yrs old) 
agreed to have their vessels used in this study (Table 1). Although medical conditions and 
medications were noted, by means of medical records (Table 1), there were no exclusions 
based on this information. All subjects included in this study had not received 
chemotherapy, as this was a contraindication for surgery. All protocols were approved by 
the Institutional Review Boards of the University of Utah and the Salt Lake City VA 
Medical Center, and written informed consent was obtained by all subjects prior to vessel 
harvesting.  
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Vessel Harvest  
Human skeletal muscle feed arteries from the axillary and inguinal regions were 
obtained during elective surgeries for melanoma at the Huntsman Cancer Hospital, 
University of Utah. Patients were anaesthetized using a standard protocol including 
propofol, fentanyl, benzodiazepines, and succinylcholine. After removal of sentinel 
lymph nodes, skeletal muscle feed arteries in the axillary (e.g. serratus anterior, or 
latissimus dorsi) or inguinal (e.g. hip adductors, or quadriceps femoris) regions were 
identified and classified as feed arteries based on entry into a muscle bed, structure, 
coloration, and pulsatile bleed pattern. The vessels were ligated, excised, and 
immediately placed in iced isotonic saline and brought to the laboratory within 15 
minutes of harvesting. Vessels were dissected under a stereo microscope at room 
temperature in normal physiological saline solution (NPSS) (125 NaCl, 4.7 KCl, 1.2 
KH2PO4, 1.2 MgSO4, 2.5 CaCl2, 18 NaHCO3, 0.026 Na2EDTA, and 11.2 Glucose mM). 
All NPSS solutions and drugs were newly prepared on the morning of the experiment. 
Vessel internal diameter was measured using a calibrated micrometer eyepiece and 
reported in micrometers (µM). Perivascular adipose tissue was dissected from the feed 
arteries. NPSS was continuously aerated with carbogen gas (95% oxygen, 5% carbon 
dioxide), and pH was monitored at regular intervals and maintained at pH 7.35 – 7.45 by 
altering the amount of aeration (Orion 3 Star, Thermo Scientific, Waltham MA). Vessels 
were dissected into four rings measuring approximately 2 mm in length, and mounted in 
wire myography chambers (700 MO, DMT Systems, Aarhus, DK). Once mounted, vessel 
chambers were also aerated with the same carbogen gas mixture, and chamber NPSS was 
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exchanged at 10 minute intervals, except during cumulative drug dose responses. Vessel 
chambers were warmed to 37˚C over a 30 minute equilibration period prior to the 
protocol.      
 
Vessel Function Protocols 
The experimental timeline is illustrated in Figure 1. All vessel segments 
underwent length tension procedures at 37˚C to determine the length at which the vessels 
produced the greatest tension in response to a single dose of 100mM KCl (Lmax) (35). 
Lmax was operationally defined as less than a 10% improvement in developed tension in 
response to 100mM KCl. The viability of all vessels was characterized using KCl (10-
100mM), phenylephrine (PE; 10-9 – 10-3 M), and acetylcholine (ACh; 10-7 – 10-3 M) dose- 
response curves to determine non-receptor- and receptor-mediated vasocontraction and 
vasorelaxation at 37˚C. All vasorelaxation responses are expressed as percent relaxation 
(%) from PE precontraction. Temperature changes were achieved by changing myograph 
chamber and solution temperature utilizing multiple water baths set to the corresponding 
temperatures. Temperatures of 35, 37, and 39˚C were chosen as they can be achieved 
under physiologic conditions, either during cold exposure, normothermia, or during 
exercise (27, 32). All feed arteries started experimentation at 37˚C to confirm normal 
vessel function (via KCl, PE, and ACh dose-response curves) prior to further 
experimental procedures (Figure 1). Single doses of PE (10-3 M) and KCl (100mM) were 
administered at 37˚C, and were then, in a balanced design, randomized to either 35 or 
39˚C. All vessel segments were exposed to all temperatures, though to minimize the 
potential for an ordering effect, the temperature perturbations away from 37˚C were 
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balanced with an equal number of vessels starting with either 35 or 39˚C, and were then 
crossed over to the remaining temperature. Each experimental protocol was separated by 
30 minutes. To determine endothelium-independent vasorelaxation, a sodium 
nitroprusside (SNP; 10-9 – 10-4 M) dose-response curve was performed in all vessels at 
37˚C, and was conducted last in every case because of its known effect of abolishing 
vessel reactivity in vitro.  
In addition to these main vessel function studies, three supplemental studies were 
performed. In the first, complete dose-response curves for PE were performed across 
each temperature in a longitudinal design, as in the main vessel function studies (Figure 
1). In the second, complete dose-response curves for PE were again performed at 35˚, 
37˚, and 39˚C, but this time in a cross-sectional design, where each vessel only 
experienced a single temperature. The developed tension (current tension – baseline 
tension) at each PE dose, for each condition, was expressed as a percent of the maximal 
tension developed at 37˚C. Finally, a third supplemental study examined stability of the 
preparation and the potential for tachyphylaxis with repeated contractions. Specifically, 
time control experiments were performed using repeated single doses of 1 mM PE and 
100mM KCl, each separated by at least 30 minutes to replicate the timing employed in 
the main studies in which each experimental protocol was separated by 30 minutes. All 
the vasocontraction responses were expressed as percent of initial tension. For each of 
these supplemental studies, subject and vessel characteristics were also assessed.  
All data were acquired at 4Hz using an analog-to-digital data acquisition system 
(Biopac Systems, Goleta, CA) to monitor vessel tensions and allow later offline analyses. 
In the majority of cases (including supplemental studies), the data represent the average 
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response of vessel rings in four chambers (average number of baths was 3.2 ±0.4 for each 
patient; CV across rings = 10-14%). 
 
Statistical Analyses  
Statistical analyses were performed using commercially available software (SPSS 
v. 17, Chicago, IL). A non-linear slope analysis and one-way repeated-measures Analysis 
of Variance (ANOVA) were performed on the PE dose-response data to determine the 
effect of temperature on PE-induced vasocontraction across doses. Two-way Repeated-
Measures ANOVA were utilized to determine if an interaction existed between order (2 
levels; 35 or 39˚C) and temperature (3 levels; 37, 39, 35˚C) on baseline tension and in the 
vasocontraction response to phenylephrine and KCl. One-way repeated-measures 
ANOVA were used to determine if time control data differed over time and if 
vasocontraction was different between 35 and 39˚C when expressed as a percent change 
from 37˚C. Significant differences were further analyzed using Tukeys’ Least Significant 
Difference post hoc test to make pairwise comparisons. Intraclass correlation coefficient 
analyses were performed on the time control experiments to determine the stability of the 
preparation for both PE- and KCl-mediated vasocontraction. The level of significance 
was set to p < 0.05. All data are reported as mean +/- standard error (SE).   
 
Results 
Subject Characteristics 
The subject characteristics, attained by medical records for all studies (main and 
supplemental), are listed in Table 1. The subjects were varied in terms of demographics 
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(e.g. age), and tended to be overweight and with evidence of systolic hypertension, 
although it should be noted that these blood pressures were obtained during preoperative 
examination. Given the blood chemistry and complete blood count (CBC) results (Table 
1), which were on average within normal range except for creatinine, which was slightly 
elevated, the subjects appeared otherwise to be relatively healthy.  
 
Vessel Characteristics 
Thirty-two human arteries were successfully harvested (19 inguinal, 13 axial). No 
statistical differences in Lmax, vasocontraction or vasorelaxation responses were observed 
in terms of anatomical location (axial vs. inguinal) or gender (male vs. female). 
Consequently, responses from all vessels were combined. The average unpressurized 
internal diameter for these feed arteries was 500 ± 200 µM. Baseline tensions prior to 
KCl and PE contractile function curves were 105 ± 29 mg and 106 ± 33 mg, respectively. 
Vessel function protocols revealed robust vasocontraction (peak KCl 2009 ± 407 mg and 
peak PE 1974 ± 508 mg) (Figure 2, panel A and B). Vessels were precontracted to 1460 
± 330 mg of tension prior to ACh and SNP dose-response curves, corresponding to 
approximately 70% of the maximal PE response, and from this point feed artery segments 
achieved significant vasorelaxation (max SNP 102 ± 6 and max ACh 73 ± 10 % 
relaxation) (Figure 2, panel C and D). Taken together, these results indicate the feed 
arteries had functional smooth muscle, α1-adrenergic receptors, and an intact 
endothelium. Interestingly, there was no relationship between α1-adrenergic 
responsiveness, KCl-induced contraction, or the ratio of these two variables and age. 
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Temperature and α1-mediated Vasocontraction  
In the main protocol, baseline tensions were lower with a temperature of 35˚C 
(111± 42 mg) or 39˚C (85± 39 mg) as compared to 37˚C (158 ± 42 mg) (p < 0.05). There 
was a decreased vasocontractile response to a single dose of PE as a consequence of 
altering temperature from 37˚C (1478 ± 338 mg), to either 35˚C (546 ± 104 mg) or 39˚C 
(896 ± 202 mg) (p < 0.05 vs. 37˚C) (Figure 3, panel B). Cooling tended to attenuate 
vasocontraction more so than heating; however, this trend did not achieve statistical 
difference (PE-induced vasocontraction at 35 vs. 39˚C; p = 0.07). However, when 
expressed as percent change from 37˚C, the vasocontraction at 35˚C was significantly 
more attenuated than that at 39˚C (p < 0.05; 53.5 ± 7.1 vs. 20.6 ± 12.3 %, respectively). 
The supplemental studies also indicated that altering temperature prior to a phenylephrine 
dose-response curve significantly reduced α1-mediated vasocontraction at both 35 and 
39˚C (Figure 4; p < 0.05 35 and 39˚C vs. 37˚C) utilizing either a longitudinal (panel A) or 
cross-sectional (panel B) study design. Additionally, standard curve analysis revealed a 
reduced Hillslope at 35 and 39˚C, as compared to 37˚C, indicating a reduced α1-receptor 
sensitivity with altered temperature. 
 
Smooth Muscle Function  
In the main protocol, baseline tensions prior to KCl were lower with a 
temperature of 35˚C (127 ± 46mg) or 39˚C (107 ± 40mg), as compared to 37˚C (207± 
35mg) (p < 0.05). The effects of temperature were not due to altered inherent smooth 
muscle function, as measured by KCl-mediated vasocontraction, evidenced by a lack of 
effect (p = 0.96) of changing temperature from 37˚C (Figure 3, panel A). Additionally, 
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the temperature effects did not appear to be the result of the passage of time, as the time 
control experiments revealed significant intraclass correlation coefficients for repeated 
single doses of KCl (0.964, p < 0.001) and PE (0.873, p < 0.01) over time (Figure 5), and 
responses were not different across time (p > 0.10). These time intervals were similar to 
those employed in the protocols that did reveal differences in PE-induced tension at 
different temperatures. Furthermore, all vessels achieved complete relaxation in response 
to SNP at the end of the experiment, providing additional evidence of intact inherent 
smooth muscle function after exposure to different temperatures. Taken together, these 
data provide evidence in support of the stability of the preparation, and indicate that the 
effect of temperature on α1-mediated vasoconstriction is not the result of altered inherent 
smooth muscle function. 
 
Discussion 
The successful harvesting of human skeletal muscle feed arteries, their 
characterization, and subsequent use in an in vitro isolated vessel study documents the 
usefulness of this approach to better understand human vascular control. Beyond this 
novel approach, the main finding of this study was that a change in temperature from the 
homeostatic set point (37˚C) reduced α1-mediated vasocontraction in human skeletal 
muscle feed arteries. Of importance, this observation was determined to not be a 
consequence of altered inherent smooth muscle function. Thus, in combination, these 
data reveal an “inverted U” response, such that α1-receptor responsiveness in human 
skeletal muscle feed arteries is temperature dependent. The potential implications of this 
finding are discussed. 
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Hyperthermia and Inherent Smooth Muscle Function  
Elevated temperature may alter inherent smooth muscle function, as some in vitro 
findings have also revealed an altered depolarization-induced contraction (23, 28), 
although not all agree (38). This clearly has the potential to confound findings that 
suggest heating results in altered receptor-mediated vasoconstriction. Although the 
current study did reveal an altered baseline tension, indicating an altered basal smooth 
muscle tone, this change was diminutive, particularly in light of such large reductions in 
α1-mediated vasocontraction, and stable KCl-mediated vasocontraction across 
temperature. In addition, the seminal works of Vanhoutte and Shepard (38) concluded 
that temperature does not exert its effect through reduced inherent smooth muscle 
contractility, which is in accordance with the results of the current study (Figure 3, panel 
A).  
 
Effects of Hyperthermia on Vasoconstrictor Agents  
Hyperthermia has previously been demonstrated to attenuate adrenergic mediated 
vasoconstriction in vivo in humans (2, 40) as well as in animal studies utilizing in vivo or 
in vitro approaches (18, 22-25, 30). However, not all agree, with recent evidence from 
Keller and colleagues (15) indicating that adrenergic responsiveness may be preserved 
during isolated heat stress in humans in vivo. Indeed, Keller et al. (2010) concluded that 
passive leg heating increases muscle blood flow and that, despite an apparent intact 
adrenergic sensitivity, whole limb vascular conductance remained significantly elevated 
with local hyperthermia in the face of clear sympathomimeticly-induced vasoconstriction 
in the femoral artery. In contrast, in vitro, utilizing the isolated rat femoral artery, Kluess 
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et al. (2005) found that heating had no effect on PE-induced vasocontraction, but reduced 
purinergic-mediated vasocontraction (16). As already indicated, Keller et al. (15) found 
no such effect, indicating, not surprisingly, that the femoral is not involved in the 
generation of resistance in vivo. In this context, the negative findings of Kluess and 
colleagues, again studying the femoral, but this time in rats, are also not surprising (16). 
In fact, the present study appears to be the first to indicate that local heating can reduce 
α1-adrenergic responsiveness in human feed arteries, an important site of blood flow 
regulation (33, 39). As the skin, although likely effected by differing mechanisms, has 
been extensively studied, it is interesting to note that the current data from feed arteries 
respond in a similar fashion to cutaneous vessels with respect to heating (40). 
While not directly assessed in the current study, the effect of elevated temperature 
on agonist-receptor interaction may, in fact, be non-selective (17, 24), although not all 
agree (16). Indeed, Massett and colleagues (24) found, in vitro, in rat vessels that 
increasing temperature not only reduced norepinephrine mediated vasocontraction, but 
also the vasocontractile response to endothelin-1, and angiotensin II. Therefore, it is 
likely that heating results in an attenuation of receptor-mediated vasoconstriction that 
may be indiscriminant of receptor type. It appears that attenuated temperature-dependent 
receptor-mediated vasoconstriction, as demonstrated here in human feed arteries with 
phenylephrine (Figures 3 and 4), may serve as an autoregulatory mechanism that 
increases perfusion to metabolically active skeletal muscle.  
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Temperature, α1-mediated Responsiveness, and Functional Sympatholysis  
The precise factor or combination of factors that contribute to functional 
sympatholysis has yet to be identified in humans. Indeed, during exercise, many variables 
likely contribute to functional sympatholysis (e.g. K+, nitric oxide, ATP, H+, etc.); 
however, a local elevation in temperature is also a potential candidate (3, 16) which has 
not been thoroughly examined, especially not in human feed arteries. The increase in 
skeletal muscle metabolism associated with exercise releases copious amounts of heat as 
a by-product. Indeed, as much as 65% of the energy conversion in the metabolic 
pathways may be lost as heat (20), elevating intramuscular temperature to ~39˚C during 
moderate intensity exercise (21, 32).  Mechanistically, increased temperature may 
contribute to functional sympatholysis through the direct or indirect attenuation of α1-
adrenergic vasoconstriction, decreasing vascular resistance and enhancing blood flow to 
the active skeletal muscle (3, 16).  
 
Effect of Hypothermia on Vascular Responsiveness  
Previous in vitro animal studies have revealed that cooling alters receptor- 
mediated vasocontraction in both cutaneous veins and arteries in skeletal muscle (11, 13). 
Faber (1988) found that cooling appeared to exert a direct effect on basal vasomotor tone 
such that, upon cooling, vessels exhibited a transient vasorelaxation, revealing a 
suppressant effect of cooling on vascular tone. In terms of α-adrenergic stimulation, it 
appears that cooling selectively attenuates α1-mediated vasocontraction, whereas α2-
induced vasocontraction remains intact or increased perhaps to compensate for reduced 
α1 responsiveness (11, 13). More recently, another elegant series of experiments 
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performed by Flavahan and colleagues (1, 4-6, 9, 10) has provided convincing evidence, 
in cells and cutaneous arteries, that cold exposure induces translocation of previously 
quiescent α2c-adrenergic receptors, in part mediated by reactive oxygen species, towards 
the cell surface which increases vasoconstriction to selective α2c-adrenergic agonists. 
However, this effect was not apparent with α1-adrenergic agonists (4), as the response to 
PE was unaffected by cold exposure which contrasts somewhat with the current finding 
of reduced α1-adrenergic responsiveness with cooling. Although in vivo cold exposure is 
well known to stimulate a reduction in cutaneous blood flow to maintain core 
temperature, very little is known regarding the specific effect of a fall in temperature on 
skeletal muscle blood flow.  
 Teleologically, and in a not too dissimilar scenario to voluntary exercise and 
heating, it is possible that cold-mediated sympatholysis plays a role in supporting the 
metabolic demand associated with shivering thermogenesis during cold stress (7). Indeed, 
cold exposure in humans has been documented to increase cutaneous vascular resistance, 
which resulted in a stroke volume-induced increase in cardiac output and prevented any 
decrement in MAP, despite a significantly reduced total peripheral resistance (29). While 
blood flow to the thermogenically active skeletal muscle was not measured in this study, 
the current data suggest that during cold exposure, blood flow to deep skeletal muscle 
may increase to support shivering thermogenesis, ultimately reducing resistance in the 
skeletal muscle vasculature. However, this observation may only be evident in arteries 
feeding deep skeletal muscle, such as those feed arteries used in the current study, and is 
likely only to be of significance under prolonged and severe cooling conditions that 
cannot be overcome by shivering thermogenesis, but these hypotheses need to be 
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confirmed in vivo. Potential explanations for the observed reduction in α1-adrenergic 
responsiveness in the current study (Figures 3 and 4) include reduced membrane 
permeability, decreased diffusional capacity, or a conformational change in the 
adrenergic receptor as a consequence of cooling (12, 19). Reduced adrenergic 
responsiveness could be a mechanism by which cold-induced vasodilation occurs (14) 
and may augment pathological hypotension during hypothermia (36). 
 
Origin of the Vessel  
The subjects who took part in this study were certainly heterogeneous in terms of 
age, gender, and health, but, although exhibiting a tendency to be overweight and some 
evidence of systolic hypertension (although obtained during preoperative examination), 
they were taking minimal medications and had normal blood chemistry and CBC data 
(Table 1). However, it should also be recognized that these subjects were undergoing 
prophylactic surgical treatment for melanoma and vessels were harvested during sentinel 
node dissection, although most lymph nodes were found to be negative for melanoma 
metastasis via Polymerase Chain Reaction analysis. In addition, it is of note the lactate 
dehydrogenase values (considered to be a crude indicator of metastasis), were within the 
normal range for all subjects and subjects were not undergoing any chemotherapy.  
Despite rather varied origin, the novel approach of harvesting these human 
arteries during such surgeries yielded the expected receptor-mediated and non-receptor-
mediated vasocontraction and vasorelaxation characteristics (Figure 2), suggestive of 
normal physiology. With our historical interest in limb specific vascular differences (41) 
and each harvest site (axial and inguinal) being associated with either the upper or lower 
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extremities, it was anticipated that vessel characteristics may vary by limb proximity. 
However, although the magnitude of within-site structural heterogeneity was of interest, 
this variation was too great to reveal any limb-specific information. Therefore, despite a 
group of heterogeneous subjects, varied vessel harvest location (i.e. axial and inguinal) 
and potential pathology, the notion that temperature exhibited a common effect speaks to 
the robust nature of this response as it relates to the regulation of sympathetically 
mediated vasoconstriction. Specifically, independent of age, gender, or disease status, 
altering the temperature from the homeostatic set-point significantly attenuates α1-
mediated vasocontraction. 
 
Limitations  
While the novel approach of harvesting human skeletal muscle feed arteries 
affords a unique experimental paradigm, it was not achieved without limitation. The 
human feed arteries used in the current study were inarguably heterogeneous (i.e. harvest 
location, vessel size, age, gender, medications, health, etc.) and this could be considered a 
limitation of this study. However, a repeated measures design was employed specifically 
to reduce the impact of interindividual variation. Additionally, although relatively small, 
some tachyphylaxis was observed in the time control studies (Figure 5), and thus may 
have contributed to the reduction in PE-induced tension development observed during 
measurements at subsequent temperatures. However, in supplemental studies, when PE 
dose responses at the different temperatures were performed in a cross-sectional design, 
to avoid any time/tachyphylaxis effects, essentially the same temperature-dependent 
results were observed (Figure 4, panel B). Additionally, it is also acknowledged that in 
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these supplemental and time control studies tension development was, on average, lower 
than the main protocol. This was attributed to differences in vessel caliber and arterial 
ring length and an unavoidable consequence of limited human feed artery availability. 
However, despite these differences, it is important to note that the functional 
characteristics of the vessels included in these supplemental studies were not different 
from those utilized in the main protocol. Finally, a reduction in baseline tension over time 
was also observed, which may have altered the contractile response to PE. However, it 
should be noted that KCl-induced tension remained stable across temperature, and the 
magnitude of the baseline shift (~70 mg tension) is highly unlikely to account for the 
dramatic reduction in tension (~500 mg tension) observed during the temperature 
perturbations.  
 
Conclusion  
Altering temperature, by either cooling or heating, reduces the contractile 
response of human skeletal muscle feed arteries to the α1-adrenergic receptor agonist 
phenylephrine in vitro. Importantly, these findings were independent of alterations in 
inherent smooth muscle function, as measured by KCl-mediated vasocontraction and 
have implications for human blood flow regulation in both hyperthermic and 
hypothermic conditions. 
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Table 1. Characteristics of the subject population (n = 32). 
 
 
     Mean ± SE            Normal Range  
________________________________________________________________________ 
 
Age (yr)    59.00 ± 4.2        -- 
Height  (cm)    174.00 ± 3.5        -- 
Weight (kg)    89.50 ± 6.1        -- 
Systolic Blood Pressure  135.60 ± 6.4 †        -- 
Diastolic Blood Pressure  75.10 ± 2.4   †        -- 
Glucose (mg/dl)   109.10 ± 9.3    65 – 110 
Blood Urea Nitrogen (mg/dl)  16.39 ± 1.8     6 – 21 
Creatinine (mg/dl)   1.03 ± 0.1    0.52 – 0.99* 
Albumin (g/dl)   4.17 ± 0.3    3.3 – 4.8 
Bilirubin (mg/dl)   0.37 ± 0.2    0.2 – 1.3 
Lactate Dehydrogenase (U/L) 494.45 ± 36.3    313 – 618  
Hemoglobin (g/dl)   14.40 ± 0.7    12 – 16 
WBC (K/uL)    8.12 ± 0.9     3.6 – 10.6 
RBC (M/uL)    4.61 ± 0.2    4 – 5.2   
Platelets (K/uL)   238.22 ± 20.1    150 – 400 
Hematocrit (%)   41.90 ± 1.9    36 – 46 
Lymphocyte (%)   30.30 ± 3.9    24 – 44  
Monocyte (%)    7.97 ± 1.2    0 – 12 
Neutrophil (%)   59.75 ± 3.0    36 – 66 
Eosinophil (%)   2.07 ± 0.4    0 – 5 
Basophil (%)    0.56 ± 0.1    0 – 5  
 
Medications (users/n) 
 Cardiovascular  
  Diuretic       2/32 
  Ca++ Channel Blocker     2/32 
  Statin       1/32 
  ACE inhibitor      2/32 
  Beta Blocker      1/32 
 
Thyroid 
  Levothyroxine      1/32 
 
Other 
  Insulin       1/32 
  Antibiotic      1/32 
________________________________________________________________________ 
* Average outside of normal range 
† Data obtained during pre-operative examination 
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Figure 1. Experimental Timeline. Potassium Chloride (KCl), Phenylephrine (PE), 
Acetylcholine (ACh) & Sodium Nitroprusside (SNP) concentrations in millimolar (mM) 
or log molar (10-x M). 
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Figure 2. Human skeletal muscle feed artery functional characteristics assessed at 
normothermia (37˚C). A) Non-receptor-mediated vasocontraction dose-response for 
KCl. B) Phenylephrine (PE) dose-response for α1-adrenergic mediated vasocontraction. 
C) Sodium Nitroprusside (SNP) dose-response (% relaxation from PE precontraction). D) 
Acetylcholine (ACh) dose response (% relaxation from PE precontraction). Data are 
presented as mean +/-SE (n=32). 
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Figure 3. The effect of temperature (35˚, 37˚, and 39˚ C) on the contractile response 
to (A) KCl and (B) a single dose of phenylephrine (PE) (1 mM) in human skeletal 
muscle feed arteries. * p < .05 vs. 37˚C. Data are presented as mean +/-SE (n = 14). 
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Figure 4. Phenylephrine Dose-Response Curves at 35˚, 37˚, and 39˚C in human 
skeletal muscle feed arteries assessed in both a longitudinal (A) and cross sectional 
design (B). (Temperature effect: †p < 0.05, 39 vs. 37˚C; ‡p < 0.05, 35 vs. 37˚C; * dose 
effect:  p < 0.05 vs. baseline). Note: These data represent an additional 6 feed arteries not 
represented in figures 3, or 5. Data are presented as mean +/-SE (n = 6 per panel). 
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Figure 5. Time control experiments for KCl and PE mediated vasocontraction 
expressed as developed tension (mg) at 37˚C in human skeletal muscle feed arteries. 
Note: These data represent an additional 6 feed arteries not represented in figures 3, or 4. 
Data are presented as mean +/-SE (n = 6). 
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Abstract 
 
Increases in local temperature have been found to exert a sympatholytic effect on 
the vasculature. We hypothesized that this attenuated α1-receptor sensitivity may actually 
be due to a temperature-induced increase in nitric oxide (NO) bioavailability, reducing 
the impact of the α1-adrenergic receptor agonist phenylephrine (PE). Thirteen human 
skeletal muscle feed arteries, obtained during surgeries, were dissected into 2mm rings 
and mounted on a wire myograph. All vessels underwent a stepwise length tension 
procedure to determine Lmax (≤10% increase in developed tension (mg∆) to 100mM 
Potassium Chloride; [KCl]). Vessel function was characterized using KCl, sodium 
nitroprusside (SNP), PE, and acetylcholine (ACh) dose-response curves (DRCs) to 
determine nonreceptor- and receptor-mediated vasocontraction and vasorelaxation. PE 
DRCs were performed at 37 and 39˚C, both with and without the endothelial nitric oxide 
synthase (eNOS) inhibitor L-NG-monomethyl-arginine (L-NMMA). A subset of arteries 
was exposed to 37 or 39˚C, and the protein content of eNOS and α1-adrenergic receptors 
analyzed by western blot. Maximal PE-induced vasocontraction (PEmax) at 39˚C was 
lower than at 37˚C (39±10 vs. 84±30 %KClmax). NO blockade restored vasocontraction at 
39˚C to that achieved at 37˚C (80±26 %KClmax). Western blot analyses revealed 
increased eNOS protein, but no such change in α1-receptors. These findings reveal that 
NO blockade can restore the attenuated α1-mediated vasocontraction at 39˚C to that 
achieved at 37˚C, implicating NO-bioavailability as an important component of 
functional sympatholysis. Additionally, the study highlights the important role that 
vasodilators can play in the vascular response to vasoconstrictors.  
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Introduction 
Increases in temperature have previously been documented to significantly reduce 
α1 -mediated vasoconstriction (4, 15, 20, 24, 28, 31, 46). Unfortunately, it is unclear from 
these studies whether these thermal effects are due to changes in receptor-agonist affinity, 
an effect on postreceptor signal integration, or altered inherent smooth muscle function. 
Our group (14, 15) has recently demonstrated that, in the face of reduced α1-receptor 
responsiveness, inherent smooth muscle function in human feed arteries, as assessed by 
the response to potassium chloride (KCl), was unchanged with heating to 39˚C. 
Therefore, in human feed arteries, known to be important in the distribution of blood flow 
(48), it does appear that heat exerts an effect specific to receptor-mediated 
vasoconstriction, but it cannot be ruled out that this could also be the result of 
antagonistic vasodilation. 
The pluripotent molecule nitric oxide (NO) exerts a significant vasodilatory 
effect, and is normally produced during exercise through shear stress stimulation of the 
endothelial NO synthase enzyme (eNOS) or catalyzed by neuronal nitric oxide synthase 
(nNOS) on the sarcolemma (2, 33, 41, 44). NO may directly reduce the impact of 
sympathetic nerves innervating smooth muscle (36) or relax the smooth muscle itself by 
stimulating guanyl cyclase, providing opposition to vasoconstriction (3, 5, 11, 29). As it 
appears that sympathetic discharge remains intact during exercise (27) and warming (6), 
a reduction in postjunctional receptor responsiveness to sympathetic activity is most 
likely responsible for the attenuated vasoconstriction under such conditions (8, 13, 24). 
Therefore, increased bioavailability of NO is a plausible mechanism by which heat 
mediates its effect, though relatively little attention has been paid to this issue, let alone 
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in humans.   
Previous work by Kregel and colleagues investigated the role of NO during 
heating using an in vivo sinoaortic deafferented rodent model (19). This work revealed 
that eNOS inhibition using L-NAME significantly attenuated the reduction in hind limb 
resistance observed during heating, implicating NO as a factor responsible for heat-
induced vasodilation. Using an in vitro approach, Harris et al. (2003) demonstrated that 
prior heat shock (42˚C) in rat aortas resulted in a significantly reduced vasocontractile 
response to PE, which was effectively restored with NOS blockade (12). Finally, in cell 
culture, heat exposure increased eNOS mRNA, protein expression, and activity, 
implicating heat as a stimulus for NO which could produce an antagonistic effect on 
receptor-mediated contraction (12). However, currently lacking, translational work is 
needed to determine if the aforementioned observations remain true in human arteries 
that were innervated and capable of producing vascular resistance (48).  
Consequently, performed in vitro, in the absence of endogenous sympathetic 
influence, and other metabolites, the goal of this study was to determine if NO inhibition 
would restore the heat-induced reduction in α1-mediated vasocontraction in human 
skeletal muscle feed arteries, thus implicating NO as an important modulator of heat-
induced vasocontraction. Additionally, using molecular approaches, we sought to 
determine if an upregulation in eNOS, or a downregulation of α1-receptors contribute to 
the attenuation of sympathomimetic-induced vasocontraction during heating. We 
hypothesized that: 1) increased temperature will attenuate α1-mediated vasocontraction, 
and effective blockade of eNOS will partially restore vasocontraction, and 2) increased 
temperature will also increase eNOS and/or reduce α1-receptor protein expression. 
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Methods 
Subjects and General Procedures 
 Thirteen heterogeneous subjects (5 males, 8 females, 49 ±18yrs, 36-85yrs) agreed 
to the use of their vessels in this study (Table 2). Although medical conditions and 
medications were noted, there were no exclusion criteria based on this information. All 
protocols were approved by the Institutional Review Boards of the University of Utah 
and the Salt Lake City VA Medical Center, and written informed consent was obtained 
by all subjects prior to vessel harvesting.  
 
Vessel Harvest and Preparation 
 Feed arteries supplying muscles in the axillary and inguinal regions were 
obtained during elective surgeries for melanoma at the Huntsman Cancer Hospital, 
University of Utah. Patients were anaesthetized using a standard protocol including: 
propofol, fentanyl, benzodiazepines, and succinylcholine. During the process of 
accessing sentinel lymph nodes, skeletal muscle feed arteries in the axillary (e.g. serratus 
anterior, or latissimus dorsi) or inguinal (e.g. hip adductors, or quadriceps femoris) 
regions were identified and classified as feed arteries based on entry to a muscle, 
structure, coloration, and pulsatile bleeding pattern. These feed arteries typically 
emanated from the thoracodorsal artery or the medial circumflex branch of the femoral 
artery, in the axial and inguinal regions, respectively. The vessels were ligated, excised, 
and immediately placed in iced isotonic saline and brought to the laboratory within 15 
minutes of harvesting. The feed arteries were dissected (perivascular adipose tissue, etc.) 
and cut into rings under a stereo microscope at room temperature in normal physiological 
saline solution (NPSS) (125 NaCl, 4.7 KCl, 1.2 KH2PO4, 1.2 MgSO4, 2.5 CaCl2, 18 
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NaHCO3, 0.026 Na2EDTA, and 11.2 Glucose mM). The NPSS was continuously aerated 
with carbogen gas (95% oxygen, 5% carbon dioxide), and pH monitored at regular 
intervals and maintained at pH 7.35 – 7.45 (Orion 3 Star, Thermo Scientific, Waltham 
MA). Arteries were dissected into four 2 mm rings, and mounted in wire myography 
chambers (700 MO, DMT Systems, Aarhus, DK). Once mounted, vessel chambers 
continued to be aerated with the same carbogen gas mixture, and chamber NPSS was 
exchanged at 10-minute intervals, except during cumulative drug dose-responses when 
the NPSS exchange was lengthened according to the protocol. Vessel length and diameter 
measurements were obtained using a calibrated micrometer eyepiece. Prior to vessel 
diameter measurements, the mounting pins were adjusted to 10 mg of tension to ensure 
the pins were touching the vessel wall. Diameters were assessed using the outer portions 
of the pins which were in contact with the walls of the vessel. Diameters and length are 
reported in micrometers (µM). Vessel chambers were gradually brought up to 37˚C over 
a 30-minute equilibration period prior to the protocol.      
 
Vessel Function Protocols 
All vessels underwent length tension procedures to determine the length at which 
the vessels produced the greatest tension in response to a single dose of 100mM KCl 
(Lmax) (39, 47). Lmax was operationally defined as less than a 10% improvement in 
developed tension in response to 100mM KCl. Vessel function was characterized using 
KCl (10-100mM), sodium nitroprusside (SNP; 10-9 – 10-4 M), phenylephrine (PE; 10-9 – 
10-3 M), and acetylcholine (ACh; 10-7 – 10-3 M) dose-response curves to determine 
nonreceptor- and receptor-mediated vasocontraction and vasorelaxation. All contractile 
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responses were normalized as a percent of the individual ring maximal response to 100 
mM KCl at 37˚C (%KClmax), to normalize the adrenergic mediated vasocontraction to the 
maximal functional capacity of the arterial smooth muscle for each segment (38). All 
vasodilation responses are expressed as percent relaxation towards basal tone from a PE-
induced precontraction, approximating 60-70% of the maximal response to PE.  
To determine the role of NO in mediating the attenuation of PE-induced 
vasocontraction with heating, two of four myograph chambers were increased to 39˚C, to 
one of which the nitric oxide synthase inhibitor L-NitroG-monomethyl-arginine (L-
NMMA, 10-3 M) was added prior to the phenylephrine dose-response series. The other 
two chambers remained at 37˚C to serve as controls, and again L-NMMA was added to 
one of these chambers. Effective NOS inhibition was confirmed by a lack of response to 
an acetylcholine challenge to the eNOS enzyme, with intact sodium nitroprusside 
relaxation after the challenge.  
Each experimental protocol was separated by 30 minutes. Vessel tension data 
were acquired at 4Hz using an analog to digital data acquisition system (Biopac Systems, 
Goleta, CA) allowing real-time monitoring and offline analyses. In the majority of cases, 
the data represent the average response of vessel rings in four baths.  
 
Western Blot Analysis 
 To further elucidate the role of eNOS, as a component of the mechanism by 
which heating alters vasocontraction, we performed an additional set of experiments 
examining protein content changes with heating. Specifically, in a subset of vessels with 
tissue remaining after dissection for wire myography, two vessel rings were placed in 2 
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mL cryovials containing pH balanced (~7.4), and well oxygenated NPSS. One vessel ring 
was exposed to 37 and the other to 39˚C for a period of 90 minutes, to determine if 
heating itself would alter eNOS or α1-adrenergic receptor protein expression. Vessels 
were then snap-frozen in liquid nitrogen for later analysis. The pH of the NPSS was 
measured again to confirm proper pH during the heat exposure, and was found to be 
unchanged. 
Following the differing temperature exposures, the feed arteries were placed in 
tubes containing 200 μL of ice-cold homogenization buffer [(0.05M HEPES, 0.01M 
sodium pyrophosphate, 0.01M sodium fluoride, 0.002M EDTA, 0.002M sodium 
orthovanodate, 1% Triton X-100, 10% Glycerol, and 1:100 Sigma protease inhibitor 
cocktail (Sigma, St. Louis, MO)]. Samples were homogenized and centrifuged for 15 
minutes at 13,800 g at 4°C. Supernatant then was collected and total protein 
concentrations determined [bicinchoninic acid (BCA) method] using a Synergy 4 
Microplate Reader (Biotek, Winooski, VT) with bovine serum albumin (BSA) as a 
standard. Supernatants were stored at -80°C. Equal amounts of protein were suspended in 
Laemmli loading buffer (Bio-Rad, Hercules, CA), incubated for 5 minutes at 95-100°C, 
and then resolved in a SDS-polyacrylamide gel (SDS-PAGE). Resolved proteins were 
transferred to a polyvinylidene difluoride (PDVF) membrane (Millipore Immobilon-P 
Transfer membrane; Millipore Corporation, Billerica, MA) at 4°C. Following transfer, 
the membranes were blocked with 5% nonfat dry milk in phosphate buffered saline with 
0.1% Tween-20 (PBST) for 1 hour at room temperature. Blocked membranes were 
probed with primary antibodies for eNOS, α1-adrenergic receptor, and β-actin (BD 
Transduction Laboratories, Franklin Lakes, NJ). The membranes were then washed with 
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TBST, incubated with the appropriate secondary antibody conjugated to horseradish 
peroxidase [Anti-rabbit IgG; Anti-mouse IgG (Amersham Biosciences, Piscataway, NJ], 
and visualized via enhanced chemiluminescence (ECL) (Pierce detection kit, Pierce 
Chemical Company, Rockford, IL) using a digital imaging system (BioRad Chemidoc 
XRS Imager, Bio-Rad Laboratories, Hercules, CA). Membranes were stained with 
Coomassie blue (BioRad Laboratories, Hercules, CA) for a loading control. Protein 
expression values at 39˚C were normalized as a percent of the 37˚C control.  
 
 
Statistical Analyses  
Statistical analyses were performed using commercially available software (SPSS 
v. 16, Chicago, IL). A repeated measures analysis of variance (ANOVA) was utilized to 
determine if there were differences in developed tension responses to cumulative doses of 
phenylephrine between conditions (37˚C, 39˚C, 37˚C+ L-NMMA or 39˚C + L-NMMA). 
Due to potential differences in kinetics, the individual PEmax data across conditions were 
analyzed using a one-way ANOVA. Significant differences were followed up using 
Tukeys’ Honestly Significant Difference test to make pair wise comparisons. The 
Wilcoxon signed ranks test was used to determine the effect of heating on eNOS and α1-
adrenergic receptor protein expression. Significance was established to be p < 0.05. All 
data are reported as mean ± standard error (SE). 
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Results 
Subject Characteristics  
Subject characteristics are listed in Table 2. The subjects were varied in terms of 
demographics (e.g. age), but, as a whole, should be considered relatively healthy given 
the blood pressure and blood analysis results (Table 2), as the group average was within 
normal range for each assessment.  
 
Vessel Characteristics  
The average internal diameter for these arteries was 888 ± 75 µM, and the average 
length was 2184 ± 141 µM. Baseline tensions prior to KCl and PE contractile function 
curves were 105 ± 23 mg and 104 ± 20 mg, respectively. Vessel function protocols 
revealed robust vasocontraction (peak KCl 1794 ± 279 mg and peak PE 1080 ± 190 mg). 
Vessels were precontracted using PE to 706 ± 261 mg of tension prior to ACh & SNP 
dose-response curves, corresponding to approximately 65% of the maximal PE response, 
and achieved significant vasorelaxation (SNPmax 105 ± 7, & AChmax 68 ± 7 % relaxation). 
Taken together, these results indicate functional smooth muscle, the presence of α1-
adrenergic receptors, and an intact endothelium (Figure 6). 
 
Nitric Oxide, Temperature, and Vessel Function  
Basal tone was found to be statistically different between conditions, with heating 
resulting in an increased basal tone (p < 0.05), which was significantly augmented by 
eNOS blockade using L-NMMA in both normothermic and heated conditions (Figure 7). 
However, it is important to note that these changes represent approximately only 1.3 to 
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3.3 %KClmax. There was a significant (p < 0.05) difference between conditions with 
regards to PE-induced vasocontraction at 37 and 39˚C, with, and without L-NMMA 
(Figure 8A). Post hoc pairwise comparisons indicated that heating significantly 
attenuated the response to phenylephrine at the last dose (10-3 logM) of PE (39˚C, 37.28 
± 10 %KClmax; p< 0.05); however, blockade of eNOS at 39˚C evoked a vasocontractile 
response similar to that of 37˚C (79.02 ± 27 vs. 82.77 ± 30 %KClmax, respectively; Figure 
8A). Blockade of eNOS also increased the response to PE at 37˚C (102.69± 30 %KClmax; 
Figure 8A); however, the effect of the block was not statistically significant (p > 0.05). 
Additionally, α1-adrenergic sensitivity was reduced with heating as the log EC50 was 
significantly reduced at 39˚C (p < 0.05), which was no longer different from 37˚C with 
eNOS blockade (Table 3).  
The maximal PE responses were lower (p < 0.01) at 39˚C (38.66 ± 10 %KClmax) 
as compared to 37˚C (84.45 ± 30 %KClmax); however, NOS blockade restored 
vasocontraction at 39˚C to equal that of 37˚C (80.29 ± 27 %KClmax) (Figure 8B). 
Blockade of eNOS also enhanced PE-induced vasocontraction at 37˚C (107± 31 
%KClmax), but not to the same extent as the heated condition (Figure 8B). When the 
maximal response to PE was expressed as percent increase from eNOS intact (basal) to 
eNOS blocked, the heated condition revealed a greater elevation in α1-mediated 
vasocontraction (p < 0.05), indicating an elevated basal nitric oxide tone with heating.  
 
Western Blot Analysis  
The western blot analyses revealed no significant difference in α1-adrenergic 
receptor protein expression across temperatures (Figure 9A; p > 0.05). However, for 
49 
 
vessel rings incubated at 39˚C, eNOS protein was significantly up-regulated compared to 
37˚C (Figure 9B; p < 0.05).  
 
Discussion 
The main finding of this study was that heating attenuated the vascular sensitivity 
to α1-adrenergic stimulation in human skeletal muscle feed arteries and this effect was 
reversed by NO blockade. At the molecular level, heating induced a significant increase 
in arterial eNOS protein expression, but no change in α1-adrenergic receptor protein 
expression. Thus, in an in vitro model devoid of sympathetic nerve activity and other 
skeletal muscle metabolites, heat-induced reductions in α1-mediated vasocontraction are, 
at least in part, due to an increase in NO bioavailability. Thus, the current data indicate 
that hyperemic stimuli, such as heat, may not actually induce sympatholysis, in the 
traditional sense, but at least in part, may be the result of increased vasodilatory stimuli 
(e.g. NO) and not reduced vasoconstriction per se.  
 
Heat and Vascular Reactivity  
Previous studies have demonstrated a reduction in mean arterial pressure, and/or 
reduced vasoconstrictor responsiveness during passive heating in vivo (8, 19, 20, 24, 30, 
32, 37), despite potentially significant increases in sympathetic nervous system activity 
(7, 18), and intact baroreflex sensitivity (8, 25). A common explanation for these results 
is a reduction in postjunctional receptor responsiveness. Using an in vitro approach, we 
(15) and others have documented a sympatholytic effect of heating on sympathetically 
mediated vasocontraction (4, 12, 28, 45, 46). Thus, the sympatholytic effect of heating 
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has been suggested to be specific to receptor-mediated vasocontraction, as previous 
studies have indicated that direct depolarization of the smooth muscle was not, in fact, 
altered by heating (15, 20). In contrast, in the current study, we observed an increase in 
basal tone with heating (Figure 7) providing some evidence of enhanced basal smooth 
muscle function. However, the magnitude of this effect was very small, compared to the 
effect on vasocontraction observed during the PE dose-response (<1% of the difference in 
PE-induced developed tension between conditions). Thus, at rest, under passive tension, 
heating does result in a general increase in smooth muscle activity which can enhance 
basal tone (23). However, in contrast to a previous study (23), this augmentation of basal 
smooth muscle activity does not carry over to active tension development using an α1-
receptor agonist or KCl (15), an observation that is in agreement with the seminal studies 
of Vanhoutte and colleagues (45, 46). Specifically, Vanhoutte and Shephard (46) 
concluded that the effects of temperature on venocontraction induced by agonists or 
direct electrical stimulation were not due to a direct thermal effect on the “contractile 
machinery” itself. Therefore, the suppressant effect of heating to 39˚C on α1-adrenergic 
receptor-mediated vasocontraction observed in the present study (Figure 8) does not 
appear to be the result of smooth muscle dysfunction.    
 
Temperature and Nitric Oxide  
The NOS enzyme has been determined to be a major promoter of exercise 
hyperemia, in part, by counteracting sympathetic nervous system activity (1, 9, 33-35, 
40-42). The dependency of enzymes upon temperature is a well described phenomenon, 
thus it is not surprising that NOS activity may also be potentiated by heat (12, 19). 
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Further, eNOS, itself, has previously been demonstrated to be temperature-dependent, 
with heating increasing NO and inducing vasodilation that opposes vasoconstriction (12, 
16, 17, 19), qualitatively the same as the results of the current study (Figure 8). However, 
not all studies have demonstrated an NO-dependent vasodilation and reduction in 
vasoconstrictor response with heating (22, 32) or during exercise (10). However, the 
complex processes and redundant mechanisms within the in vivo model, coupled with 
methodological considerations, may have confounded previous results which have left 
the impact of NO on vasoconstriction, during heat stress, somewhat equivocal. 
A comprehensive study by Harris et al. (12) investigated the role of heat shock on 
the regulation of eNOS in a rodent model. These researchers found that heating not only 
increased heat shock protein (HSP) expression, but also increased the eNOS protein 
signal (mRNA), protein expression, eNOS activation/phosphorylation, and eNOS 
functional activity. Therefore, it is highly likely that the increased vasodilator function 
associated with heating reduces the functional consequence of vasoconstrictors. Indeed, 
Harris et al. (12) found that heat stress reduced the maximal response to phenylephrine, 
an effect which was reversed with eNOS blockade. In agreement with this prior work 
(12), the current study revealed that heating increased eNOS protein (Figure  9), in whole 
artery homogenate, and documented greater eNOS activity with heating, as evidenced by 
the greater effect of L-NMMA at 39˚C compared to 37˚C, indicating heightened basal 
NO bioavailability with heat (Figure 8).  
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Sympatholysis as a “Tug of War”  
Historically, functional sympatholysis has been viewed under an analytical lens 
that infers, as the name implies, a “lysing” of sympathetic activity. Indeed, researchers 
have focused on the concept of reduced vasoconstrictor responsiveness, rather than a 
change in smooth muscle signal integration. However, the current data emphasize the 
potential for increased vasodilatory capacity, rather than reduced vasoconstrictor potency 
as a bone fide mechanism responsible for reduced α1-mediated vasoconstriction with 
heat, resulting in the concept of a “tug of war” between vasodilators and vasoconstrictors. 
This vasodilatory component of the process is likely postjunctional, as muscle 
sympathetic nerve activity (MSNA) and norepinephrine spillover remain intact during 
exercise (21, 26). Specific to heat, in a rodent model, increased MSNA did not prevent a 
fall in hindlimb resistance during passive heating (19), but blockade of the eNOS enzyme 
significantly attenuated this vasodilation, implicating NO, and more accurately heat-
induced changes in NO, in the observed sympatholysis. In support of this concept, 
Shibasaki et al. (37) demonstrated that NO attenuated norepinephrine-induced cutaneous 
vasoconstriction in vivo in humans. Moreover, various studies in animals have 
documented a NO-dependent abatement of sympathetic vasoconstriction (41, 43). Thus, 
based upon such prior work and the current data, it appears that a component of 
functional sympatholysis is likely an increased abundance of vasodilators, such as NO, 
rather than simply an insufficiency of vasoconstrictors, which ‘tip the balance’ in favor of 
vasodilation and subsequent hyperemia in the tug of war of vasodilators and 
vasoconstrictors during exercise.   
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Limitations  
The subjects who took part in this study were certainly heterogeneous in terms of 
age, gender, and health (Table 2). Additionally, vessels were harvested in proximity to 
sentinel node regions in individuals receiving prophylactic surgical treatment for 
melanoma. However, it should be noted that most lymph nodes of these patients were 
found to be negative for melanoma metastasis via Polymerase Chain Reaction analysis. It 
should also be noted that the novel approach of harvesting these human arteries during 
axial and inguinal surgeries yielded the expected receptor-mediated and nonreceptor-
mediated vasocontraction and vasorelaxation characteristics (Figure 6), suggestive of 
somewhat uniform and normal physiology, despite potential pathology and rather varied 
origin. Therefore, despite both a group of heterogeneous subjects and potential pathology, 
the fact that temperature and eNOS blockade exhibited a common effect across subjects 
speaks to the robust nature of this response as it relates to the regulation of 
sympathetically mediated vasocontraction. Specifically, independent of age, gender, or 
disease status, heating significantly attenuates α1-mediated vasocontraction and this 
phenomenon can be overcome by reducing NO bioavailability by eNOS blockade. 
 
Conclusion  
This study provides evidence that heat increases NO bioavailability and opposes 
α1-mediated vasocontraction in human skeletal muscle feed arteries. Thus, with the 
capacity of feed arteries to regulate skeletal muscle blood flow, heat produced, as a 
consequence of muscle contraction, has the potential to stimulate eNOS, overriding α1-
mediated vasoconstriction and thereby increasing skeletal muscle blood flow.   
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Table 2. Characteristics of the subject population (n =13). 
________________________________________________________________________ 
 
     Mean +/- SE    Normal Range 
________________________________________________________________________ 
 
Age (yr)    49 ± 17.6 (36-85)       -- 
Height  (cm)    172 ± 13.4        -- 
Weight (kg)    83 ± 19.5        -- 
Systolic Blood Pressure  133 ± 17.2 †                   -- 
Diastolic Blood Pressure  75 ± 7.6 †        -- 
Glucose (mg/dl)   98 ± 19.7    65 – 100 
Blood Urea Nitrogen (mg/dl)  16.4 ± 5.0     6 – 21 
Creatinine (mg/dl)   0.92 ± 0.2    0.52 – 0.99 
Albumin (g/dl)   4.25 ± 0.3    3.3 – 4.8 
Bilirubin (mg/dl)   0.42 ± 0.2    0.2 – 1.3 
Lactate Dehydrogenase (U/L) 440 ± 86.9    313 – 618  
Hemoglobin (g/dl)   14.20 ± 1.8    12 – 16 
White Blood Cells (K/uL)  6.78 ± 2.4     3.6 – 10.6 
Red Blood Cells (M/uL)  4.58 ± 0.6    4 – 5.2   
Platelets (K/uL)   239 ± 52.5    150 – 400 
Hematocrit (%)   41.3 ± 5.0    36 – 46 
Lymphocyte (%)   28 ± 6.2    24 – 44  
Monocyte (%)    7.7 ± 2.2    0 – 12 
Neutrophil (%)   62.8 ± 6.2    36 – 66 
Eosinophil (%)   1.72 ± 0.8    0 – 5 
Basophil (%)    0.54 ± 0.2    0 – 5  
 
Medications (users/n) 
 Cardiovascular  
  Diuretic       2/13 
  Ca++ Channel Blocker     1/13 
  Statin       2/13 
  ACE inhibitor      1/13 
  Beta Blocker      1/13 
 
Thyroid 
  Synthroid      1/13 
 
Other 
  Insulin       1/13 
  Metformin                 1/13 
________________________________________________________________________ 
† Data obtained during pre-operative examination 
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Table 3. Phenylephrine dose response characteristics at 37˚ and 39˚C and in the 
presence and absence of the eNOS inhibitor L-NG-monomethyl-arginine (L-NMMA). 
Condition    Max    Hillslope  EC50                  Log EC50  
37˚C      84.45±29 1.05±0.03          -4.19±0.02       - 6.49-5 
37˚C + L-NMMA     107.00±31         1.53±0.21         -4.25±0.07       - 5.61-5 
39˚C   38.66±10* 1.96±0.11         -4.50±0.07       - 3.14-5 * 
39˚C + L-NMMA 80.29±27 1.32±0.07         -4.31±0.04       - 4.90-5 
* p < 0.05 vs. 37˚C 
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Figure 6. Vessel function characteristics. A) Phenylephrine (PE) dose response.  B) 
Potassium Chloride (KCl) dose response. C) Acetylcholine (ACh) dose response (% 
relaxation from PE precontraction). D) Sodium Nitroprusside (SNP) dose response (% 
relaxation from PE precontraction) (n=13). 
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Figure 7. Effect of eNOS blockade and temperature on basal tension. 
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Figure 8. A) Phenylephrine dose responses at 37 and 39˚C in the presence of the eNOS 
inhibitor L-NG-monomethyl-arginine (L-NMMA), vasocontraction expressed as a percent 
of KClmax (n=13).  * Dose effect p < 0.01 vs. baseline, † Condition effect p < 0.01. B) 
Maximal Phenylephrine induced vasoconstrictor responses at 37, and 39˚C ± L-NMMA, 
expressed as a percent of KClmax. * Condition effect, p < 0.05 (n=13). 
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Figure 9. Western Blot Analyses for α1-adrenergic receptors (Panel A); and eNOS (Panel 
B), in an additional set of vessels where half of each vessel was exposed to 37 or 39˚C for 
90 minutes. * p < 0.05 37 vs. 39 (n = 4). 
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Abstract 
Graded exercise results not only in the modulation of adrenergic-mediated smooth 
muscle tone and a preferential increase in blood flow to the active skeletal muscle termed 
“functional sympatholysis,” but is also paralleled by metabolically induced reductions in 
pH. Therefore, we sought to determine if pH attenuates α1-adrenergic receptor sensitivity 
in human feed arteries. Feed arteries (560±31 µM ID) were harvested from 22 humans 
(24-86 yrs, 10 males, 12 females) and studied using the isometric tension technique. 
Vessel function was assessed using potassium chloride (KCl), phenylephrine (PE), 
acetylcholine (ACh), and sodium nitroprusside (SNP) dose-response curves (DRCs) to 
characterize nonreceptor- and receptor-mediated vasocontraction as well as endothelium-
dependent and independent vasorelaxation, respectively. PE, KCl, ACh, and SNP DRCs 
were conducted with a pH of: 7.4, 7.1, 6.8, and 6.5. Increasing acidification reduced 
maximal PE-induced vasocontraction (pH 7.4 = 85 ± 19; 7.1= 57 ± 16; 6.8 = 34 ± 15; 6.5 
= 16 ± 5 %KClmax), which was partially due to reduced smooth muscle function, as 
assessed by KCl, (pH 7.4 = 88 ± 13; 7.1= 67 ± 8; 6.8= 67 ± 9; 6.5= 58 ± 8 %KClmax). 
Graded acidosis had no effect on maximal vasorelaxation. In summary, these data reveal 
that reductions in extracellular pH attenuate α1-mediated vasocontraction, which is 
partially explained by reduced smooth muscle function, although vasorelaxation to ACh 
and SNP remained intact. These findings support the concept that local acidosis could be 
contributing to functional sympatholysis and exercise hyperemia by opposing 
sympathetically-mediated vasoconstriction and by not impacting vasodilation. 
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Introduction 
In 1880, Gaskell originally proposed that acidosis could exert a suppressant effect 
on vasculature tone (10), and this hypothesis has since been confirmed by other 
researchers who found, in vivo, that hypercapnic acidosis was capable of producing 
significant hyperemia (7, 8, 20-22). Interestingly, exercise of sufficient intensity results in 
acidosis within the active muscle bed (32, 38) and is also correlated with profound 
hyperemia (3). In parallel, exercise is associated with a reduction in vascular 
responsiveness to both endogenous sympathetic nerve activity (31), or exogenous 
sympathomimetics (48), termed “functional sympatholysis” (31). 
In a series of in vitro studies, Faber and others (25, 37, 40) sought to determine if 
the acidosis-induced hyperemia previously observed in vivo was the result of altered 
vascular reactivity to sympathetic neurotransmitters, as in functional sympatholysis 
during exercise. In the in vitro rodent model, it was determined that arteriolar α2-
adrenergic function was disrupted with acidosis, leaving α1-receptor function intact (18, 
25, 27, 40, 41). However, other studies that have used a similar approach to determine if 
acidosis could attenuate agonist-induced vasoconstriction are equivocal, revealing an 
increase (33, 34), decrease (14, 25, 27, 30, 34, 37), or no change (18, 25, 27, 40) in the 
maximal response or sensitivity to an agonist (e.g. norepinephrine or PE). Additional 
studies have determined that the disparate effect of pH upon vasocontraction may depend 
upon species (27), rodent strain (34), vascular location and caliber (12-15, 24), and 
experimental model (6, 33, 36).  
With the knowledge that species and vascular location/caliber alter the response 
to acidosis, the specific effect of acidosis on human arteries remains uncertain. An in 
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vitro study by Rohra and colleagues (36) using human internal mammary artery found 
that acidosis did, indeed, attenuate the response to a single dose of PE and KCL. The 
attenuated vasocontraction was likely the result of altered vasoconstrictor function; 
although not addressed in that study, enhanced vasodilator function could be contributing 
to the reduced vasocontraction (36). Indeed, extracellular acidosis has been demonstrated 
to induce hyperpolarization, via ion channels, which results in a reduction in vascular 
wall tension and likely opposes subsequent vasocontraction (5, 14, 24, 30, 33-36). 
However, it has yet to be tested if agonist-induced vasorelaxation, and thus the balance 
between vasocontraction and vasorelaxation, are altered during acidosis.  
In rodent skeletal muscle it has been established that a primary control point for 
regulating total muscle blood flow during exercise is the feed artery (43-47). Human 
skeletal muscle feed arteries, while relatively large compared to the equivalent vessels in 
rodents, are by human standards very small (1-2% of aortic diameter) and have a similar 
anatomical location. Therefore, human feed arteries also likely contribute significantly to 
blood flow regulation by varying vascular resistance prior to entry into the muscle bed. 
Although difficult to obtain, human skeletal muscle feed arteries can, in fact, be harvested 
during certain surgical procedures and studied in vitro (17). It remains unknown if 
acidosis, a consequence of exercise, plays a significant role in modulating 
vasocontraction of human skeletal muscle feed arteries, considered to be a point of blood 
flow regulation. 
Accordingly, with the novel approach of harvesting human skeletal muscle feed 
arteries, the purpose of this study was to determine the effect of pH on vascular reactivity 
in these arteries. Specifically, we sought to determine the effect of acidosis on α1-
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adrenergic receptor responsiveness and the role of smooth muscle and endothelial 
function in mediating this process. We tested 3 hypotheses: Reductions in the pH of the 
medium surrounding human skeletal muscle feed arteries will 1) attenuate α1-adrenergic 
receptor responsiveness, 2) attenuate inherent smooth muscle function, and 3) enhance 
endothelium dependent vasodilation. If confirmed, such findings would implicate 
acidosis as a contributor to the local regulation of skeletal muscle blood flow by the feed 
artery and offer insight into the mechanisms responsible for functional sympatholysis 
during exercise. 
 
Methods 
Subjects and General Procedures  
A heterogeneous group of 22 subjects (10 males and 12 females, 54 ± 4 yrs, range 
24-86 yrs) agreed to have their vessels used in this study (Table 1). Although medical 
conditions and medications were noted, there were no exclusions based on this 
information. All protocols were approved by the Institutional Review Boards of the 
University of Utah and the Salt Lake City VA Medical Center, and written informed 
consent was obtained from all subjects prior to vessel harvesting.  
 
Vessel Harvest  
Human skeletal muscle feed arteries from the axillary and inguinal regions were 
obtained during elective surgeries for melanoma at the Huntsman Cancer Hospital, 
University of Utah. Patients were anaesthetized using a standard protocol including: 
propofol, fentanyl, benzodiazepines, and succinylcholine. After removal of sentinel 
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lymph nodes, skeletal muscle feed arteries in the axillary (e.g. serratus anterior, or 
latissimus dorsi) or inguinal (e.g. hip adductors, or quadriceps femoris) regions were 
identified and classified as feed arteries based on entry into a muscle bed, structure, 
coloration, and pulsatile bleed pattern. The vessels were ligated, excised, and 
immediately placed in iced isotonic saline and brought to the laboratory within 15 
minutes of harvesting. Vessels were dissected under a stereo microscope at room 
temperature in normal physiological saline solution (NPSS) (125 NaCl, 4.7 KCl, 1.2 
KH2PO4, 1.2 MgSO4, 2.5 CaCl2, 18 NaHCO3, 0.026 Na2EDTA, and 11.2 Glucose mM). 
All NPSS solutions and drugs were newly prepared on the morning of the experiment. 
Vessel internal diameter was measured using a calibrated micrometer eyepiece and 
reported in micrometers (µM). Perivascular adipose tissue was dissected from the feed 
arteries. NPSS was continuously aerated with carbogen gas (95% oxygen, 5% carbon 
dioxide), and pH was monitored at regular intervals and maintained at pH 7.35 – 7.45 by 
altering the amount of aeration (Orion 3 Star, Thermo Scientific, Waltham MA). Vessels 
were dissected into four rings measuring approximately 2 mm in length, and mounted in 
wire myography chambers (700 MO, DMT Systems, Aarhus, DK) to be studied using the 
isometric tension technique (29), as employed previously by our group (17). Once 
mounted, vessel chambers were also aerated with the same carbogen gas mixture, and 
chamber NPSS was exchanged at 10-minute intervals, except during cumulative drug 
dose responses. Vessel chambers were brought up to 37˚C over a 30-minute equilibration 
period prior to the start of a protocol.     
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Characterization of Vessel Function  
All vessel segments underwent length tension procedures at 37˚C to determine the 
length at which the vessels produced the greatest tension in response to a single dose of 
100mM KCl (Lmax) (39). Lmax was operationally defined as less than a 10% improvement 
in developed tension in response to 100mM KCl. The viability of the vessels was 
characterized using KCl (10-100mM), PE (10-9 – 10-3 M), SNP (10-9 – 10-4 M), and ACh 
(10-7 – 10-3 M) dose-response curves to determine nonreceptor- and receptor-mediated 
vasocontraction and vasorelaxation. All vasocontractile responses are expressed as a 
percent of the individual maximal response to 100mM KCl (%KClmax) as described 
previously (42). All vasorelaxation responses are expressed as percent relaxation (%) 
from PE precontraction.  
 
pH and Vascular Reactivity  
Changes in pH were achieved by adding specific volumes (13 – 38 μL) of 
hydrochloric acid (1N HCl) to the myograph chamber, an approach that has been utilized 
previously (6, 36). Pilot work was performed, without vessels, to determine the 
appropriate volume of HCl necessary to achieve a target pH. Specifically, 30 different 
volumes of HCl were added separately to the myograph chamber containing a 
bicarbonate free medium and, after a similar time to that required to perform a 
cumulative dose-response, the pH was measured and a linear regression between pH and 
HCl volume was constructed. This pH to volume relationship was subsequently tested to 
determine efficacy and pH was confirmed post hoc in each myograph chamber after each 
protocol. Myograph chamber pH of 7.4 (control), 7.1, 6.8, and 6.5 were chosen as they 
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can be achieved during exercise (32). Under these conditions, the PE and KCl dose-
responses were performed, in a balanced manner, to determine the effect of acidosis on 
vasocontraction. To determine the effect of acidosis on vasorelaxation or the sensitivity 
to the vasodilatory substances ACh (endothelium-dependent; 10-7 – 10-3 M) and SNP 
(endothelium-independent vasorelaxation; 10-9 – 10-4 M), dose-response curves were 
constructed. The SNP trials were conducted last in every case because of the known 
effect of SNP to irreversibly abolish vascular reactivity in vitro. All data were acquired at 
4Hz using an analog to digital data acquisition system (Biopac Systems, Goleta, CA) to 
monitor vessel tensions and allow later offline analyses.  
 
Statistical Analyses  
Statistical analyses were performed using commercially available software (SPSS 
v. 16, Chicago, IL). Two-way Repeated-Measures ANOVA were utilized to determine if 
an interaction existed between pH (4 levels; 7.4, 7.1, 6.8, 6.5) and dose in the 
vasoreactivity to each agonist (PE, KCl, ACh, SNP) with varying pH. Due to potential 
individual differences in kinetics, the individual maximal response for each agonist (KCl, 
PE, ACh, SNP) was analyzed using a one-way repeated-measures ANOVA. Significant 
differences were assessed using Tukeys’ Least Significant Difference post hoc test to 
make pairwise comparisons. To determine if increasing acidosis altered the sensitivity to 
an agonist, standard curve analyses were performed using commercially available 
software (BioDatafit v. 1.02, Castro Valley, CA). The level of significance was 
established at p < 0.05. All data are reported as mean ± standard error (SE).   
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Results 
Vessel Characteristics  
Twenty-two human skeletal muscle feed arteries were successfully harvested 
(Table 4). No statistical differences in Lmax, vasocontraction or vasorelaxation responses 
were observed in terms of anatomic location (axial vs. inguinal) or sex. Consequently, 
responses from all vessels were combined. The average internal diameter with minimal 
tension for these feed arteries was 560 ± 31 µM, and measured 1650 ± 75 uM in length. 
Vessel function protocols revealed robust vasocontraction in response to PE and KCl (83 
± 19; 87 ± 13 %KClmax, respectively; Figure 10A and B). Vessels were preconstricted to 
approximately 70% of the maximal PE response prior to ACh and SNP dose-response 
curves, and from this point, feed artery segments achieved significant vasorelaxation (102 
± 16; 78 ± 8 % relaxation, respectively) (Figure 10C and D). Taken together, these results 
indicate the feed arteries had functional smooth muscle, α1-adrenergic receptors, and an 
intact endothelium.  
 
pH and Vasocontraction  
Reducing extracellular pH significantly attenuated vascular tension development 
in response to both the α1-adrenergic agonist PE, and KCl (Figure 11A and B). Reducing 
pH significantly attenuated KCl induced vasocontraction (pH effect p < 0.05; dose effect 
p = 0.000), but there was no difference in the maximal responses (Figure 11C). However, 
there were differences in the sensitivity to KCl, as the EC50 and logEC50 were altered 
with acidosis, though not in a graded manner as with PE (Table 5). The suppressant effect 
of incremental acidosis was evident in response to cumulative doses of PE (pH x dose p = 
 75
0.000; pH effect p = 0.000; dose effect p = 0.000; Figure 11A). In addition, the EC50 and 
logEC50 for PE were clearly increased, indicating a reduced sensitivity of the arterial 
rings in acidotic conditions exposed to the same dose of PE (Table 5). When expressed as 
percent change from control (pH 7.4), the effect of pH on the arteries was more 
pronounced in response to PE, when compared to KCl (Figure 11C).     
 
pH and Vasorelaxation  
The ACh (endothelium-dependent) and SNP (endothelium-independent) 
vasorelaxation responses were performed with graded reductions in pH to determine if 
net relaxation or relaxation kinetics were altered by acidosis. There was no significant 
effect of graded reductions in pH on the maximal vasorelaxation in response to either 
ACh or SNP (Figure 12). The sensitivity of the smooth muscle to the vasodilatory effects 
of SNP, assessed by EC50 and logEC50, was reduced from pH 7.4, at pH 7.1 and 6.5, 
suggestive of reduced smooth muscle function (Table 5). However, graded acidosis 
significantly enhanced the sensitivity to ACh, again as assessed by the EC50 and logEC50 
(Table 5), indicating heightened endothelial sensitivity.  
  
Discussion 
The main finding of this study was that graded reductions in extracellular pH 
resulted in significant and progressive decreases in the response to sympathomimetic 
stimulation. This attenuated response to the α1-adrenergic agonist PE cannot be fully 
explained by the much smaller concomitant suppression of smooth muscle function. In 
stark contrast to the detrimental impact of acidosis on vasocontraction, there was no 
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significant effect on endothelium-dependent or -independent maximal vasorelaxation, 
with some evidence of enhanced sensitivity to the endothelium-dependent agonist ACh. 
These results reveal, for the first time in human skeletal muscle feed arteries, that not 
only does acidosis suppress vasocontractile capacity, but this phenomenon may also be 
enhanced by unaltered or even enhanced vasodilatory function. Therefore, these findings 
imply that acidosis, associated with skeletal muscle metabolism, could be a contributing 
factor in the reduction of sympathetically mediated vasoconstriction, or functional 
sympatholysis, observed during exercise by reducing vasocontractile function yet leaving 
vasodilatory function intact, ultimately producing significant reductions in vascular 
resistance.   
 
pH and Vasocontraction  
As already indicated, en masse, the results of studies that have attempted to 
determine the effect of acidosis on agonist-induced vasoconstriction remain unresolved. 
Although early studies focused on the receptor-mediated responses (25), later studies 
acknowledged that any observed reduction in agonist-induced vasocontraction could be, 
at least in part, mediated by altered inherent smooth muscle function (40). Most studies 
(1, 2, 5, 15, 30)  now agree that acidosis exerts a direct effect on the vascular smooth 
muscle, via ion channels (ATP sensitive K+ channels in particular), which may act in 
conjunction with reduced receptor sensitivity resulting in an attenuated maximal receptor-
mediated responsiveness. In light of this, Rohra et al. (36) used the receptor-independent 
agonist KCl and receptor agonist PE to determine the effects of acidosis on 
vasocontractile function in the human internal mammary artery. Their findings indicated 
 77
that acidosis reduced KCl and, to a much greater extent, PE-induced vasocontraction 
(36). In agreement with Rohra and colleagues (36), the current findings reveal that α1-
alpha adrenergic receptor function is suppressed in a proportional fashion by reductions 
in pH (Figure 11A), which persisted across a range of doses, and is, at least in part, 
mediated by reduced smooth muscle function (Figure 11B). Also in agreement with this 
prior work in a human artery, it appears that in human feed arteries, the receptor mediated 
vasocontraction, induced by the sympathomimetic PE, is far more susceptible to the 
effects of acidosis than the nonreceptor -mediated KCl-induced vasocontraction (Figure 
11C). 
The effect of pH may, or may not, be receptor selective as Kluess et al. (18) 
documented, in the rat femoral artery, that purinergic (P2X1) and not α1-adrenergic 
receptor-mediated vasocontraction was impaired during acidosis. Although the majority 
of studies indicate acidosis is inhibitory despite the agonist employed (36), some of the 
variation in the effect of acidosis can be explained by differences in species (27), genetic 
strain (34), vascular location and caliber (12-15, 24), and experimental model (6, 33, 36). 
For example, an in vitro rodent study determined that rat strain alone created a divergent 
response resulting in either a suppressed or enhanced α1-mediated vasoconstriction in the 
face of acidosis (34). Vessel location appears to be another important determinant of the 
effect acidosis may have upon vascular tension development as cerebral and coronary 
vessels seem highly sensitive to acidosis (6, 12, 27, 30), whereas the pulmonary artery 
appears to be less so (14, 27). Additionally, vessel order appears to alter the vascular 
sensitivity to acidosis, meaning that it has been documented that smaller arterioles appear 
to be more sensitive to acidosis than larger arterioles (25, 40), which has implications for 
 78
blood flow regulation and redistribution. This also likely explains the negative findings of 
Kluess et al. (18) where there was no effect of acidosis on PE-induced vasocontraction in 
the rat femoral artery, an unlikely site of blood flow regulation. Utilizing an artery more 
likely to be involved in the regulation of skeletal muscle blood flow, our findings indicate 
the acidosis does, in fact, reduce α1-mediated vasocontraction.     
It should also be noted that studies which determined that acidosis suppressed α2- 
and not α1-adrenergic responsiveness using selective and nonselective adrenergic agonists 
employed the rat cremaster muscle model (25, 40). This model has recently been 
suggested to be unrepresentative of locomotor muscles (28), and challenges the dogma 
that terminal arterioles are primarily under α2-receptor control and more susceptible to 
“metabolic inhibition,” while proximal arteries are under α1-receptor control (4, 25, 26).  
While the classic dogma was logical and certainly an attractive hypothesis, the work of 
Moore and colleagues (28) in essence challenges the applicability of prior findings from 
the cremaster model, as they found terminal arterioles in locomotor muscle were, in fact, 
primarily under α1-receptor control, but also varied in prevalence down the arterial tree. 
In this context, and in light of the potential for the feed artery to be a locus of skeletal 
muscle blood flow regulation (43-47), the findings from the current study support the 
suppressant effect of acidosis on α1-mediated vasoconstriction, which appears to be due 
to reduced receptor sensitivity, and inherent smooth muscle function.  
 
pH and Vasorelaxation  
The vasodilatory effects of acidosis have been well described both in vitro (6, 12, 
13, 15, 16, 19, 24, 30), and in vivo in animals (7-9, 23), yet the question remains if these 
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results translate into humans. Early work in humans indicated that hypercapnia or the 
infusion of hypercapnic saline elicited a profound hyperemia (20-22). The prior human 
work, although quite impressive for the era, was not able to determine the mechanism by 
which acidosis elicited a vasodilatory effect. Subsequent animal work (6, 24) determined 
that acidosis elicited vasodilation in a dose-dependent manner, and endothelial 
denudation or pharmacological blockade reduced endothelial sensitivity to acidosis, but 
not the maximal response. The results of the current study were similar to the findings of 
these previous studies (6, 24), where the maximal response to ACh or SNP was 
unchanged (Figure 12), but the endothelial sensitivity was enhanced with graded acidosis 
(Table 5). Acidosis also reduced the sensitivity to the endothelium independent 
vasodilator SNP, but certainly not as clearly as the effect of acidosis on the ACh 
response. Thus, the effect of acidosis on vasorelaxation does not appear to be 
significantly impacted by altered smooth muscle cyclic-GMP function. To our 
knowledge, there has not been a single study that has investigated the effect of acidosis 
on agonist-induced vasorelaxation in either animals or humans. Therefore, this study 
appears to be the first to demonstrate that vasorelaxation function, both endothelial-
dependent and -independent, remains intact when exposed to physiological levels of 
acidosis.   
 
pH and the Balance between Vasoconstrictors and Vasodilators:  
Implications for Functional Sympatholysis  
There is a growing recognition that functional sympatholysis may actually be the 
alteration in the balance between sympathetic vasoconstriction and vasodilation induced 
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by metabolic by-products from muscle (11). In this context, we sought to determine the 
effect of acidosis on vasoreactivity and the varying contribution of vasorelaxation and 
vasocontractile function in this response. Additionally, utilizing receptor-dependent and 
receptor-independent agonists allowed the comparison of receptor versus smooth muscle 
function for both vasocontraction and vasorelaxation. Specifically, we determined the 
percent change in receptor-mediated function associated with acidosis (%Δ pH 7.4-6.5) 
for both PE and ACh; performing the same calculation for KCl and SNP, we then 
subtracted the percent change attributable to vascular smooth muscle for both 
vasocontraction (%ΔPE - %ΔKCl) and vasorelaxation (%ΔACh - %ΔSNP). This 
provides a theoretical approach to understand the effect of acidosis on receptor-mediated 
function for both vasocontraction and vasorelaxation, using a common unit of measure 
(%Δ). Using this subtraction approach, it is apparent that acidosis had a more profound 
effect upon receptor-mediated vasocontraction compared to vasorelaxation (Figure 13). 
In the context of exercise and functional sympatholysis, these results provide support that 
acidosis can indeed elicit a sympatholytic effect, but that the impact of this effect would 
be augmented by the concomitant maintenance of endothelium mediated vasodilation. It 
is likely that in vivo, these contrasting responses to acidosis act in concert to override 
sympathetic activity and facilitate hyperemia during exercise.   
 
Conclusions  
This study has demonstrated that local changes in pH significantly reduce α1-
adrenergic receptor function and this observation is due, at least in part, to reduced 
smooth muscle function. Interestingly, endothelium-mediated vasodilatory capacity tends 
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to be unchanged while sensitivity is increased which may act to augment the impact of 
attenuated sympathetically mediated vasocontraction. These findings support the concept 
that local acidosis could be a contributing factor in functional sympatholysis and exercise 
hyperemia by opposing sympathetically mediated vasoconstriction and by not impacting 
or increasing endothelium dependent vasodilation. 
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Table 4. Characteristics of the subject population (n =22).  
________________________________________________________________________ 
      Mean ± SE           
________________________________________________________________________ 
Age (yr)     55 ± 4         
Height  (cm)     161 ± 9         
Weight (kg)     88 ± 10         
Systolic Blood Pressure   131 ± 7 †         
Diastolic Blood Pressure   75 ± 8 †         
 
Medications (users/n) 
 Cardiovascular  
  Diuretic        2/22 
  Ca++ Channel Blocker      1/22 
  Statin     1/22 
  ACE inhibitor       0/22 
  Beta Blocker       1/22 
 
Other 
  Insulin       1/22 
________________________________________________________________________ 
† Data obtained during pre-operative examination 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 88
Table 5. Dose response curve characteristics with increasing acidosis (mean±SE). 
Drug - pH     Max (%KClmax)  EC50                  Log EC50  
PE   7.4   85±19                         3.0-5       - 4.5±0.2 
        7.1              56±16*                        6.1-5*       - 4.2±0.1* 
        6.8   34±15*             6.7-5*       - 4.2±0.1* 
        6.5   16±5*                         1.4-4*       - 3.8±0.1* 
 
KCl 7.4   88±13               6.459       59.8±0.6 
        7.1   67±8                 1.340*       40.1±0.6* 
        6.8   67±9                          8.259       59.9±0.5 
        6.5   58±8                         1.560       60.2±0.4 
 
ACh 7.4   81±8                 1.8-5       - 4.5±0.4 
        7.1   77±12                         3.2-6*         - 5.5±0.3* 
        6.8   67±7                         8.6-6*         - 5.2±0.2* 
        6.5   68±6                          9.3-7*         - 6.0±0.2*  
 
SNP 7.4   103±17             4.6-7          - 6.3±0.3 
        7.1   110±9                         1.6-7*          - 6.8±0.3* 
        6.8   107±4                         5.6-7          - 6.2±0.3 
        6.5   93±7                  1.3-6*          - 5.9±0.2* 
 
* Significantly different from pH 7.4 (p < 0.05)  
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Figure 10. Human skeletal muscle feed artery functional characteristics. A) 
Phenylephrine (PE) dose-response for α1-adrenergic-mediated vasocontraction.  B) 
Nonreceptor-mediated vasocontraction dose-response for KCl.  C) Acetylcholine (ACh) 
dose response (% relaxation from PE precontraction). D) Sodium Nitroprusside (SNP) 
dose response (% relaxation from PE precontraction). Data are presented as mean ± SE. 
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Figure 11. Vasocontractile Function and Acidosis. A) PE dose-responses across varying 
levels of acidosis. †main effect of pH, p < 0.05, *main effect of dose, significantly 
different from baseline (p < 0.05). B) KCl dose-response curves across varying levels of 
acidosis. C) Maximal PE and KCl responses expressed as a percent of control condition 
(pH 7.4).  # p < 0.05 vs. pH 7.4, § p < 0.05 vs. pH 7.1. Data are presented as mean ± SE. 
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Figure 12. Vasorelaxation Function and Acidosis. A) ACh Dose-response curves across 
varying levels of acidosis. *main effect of dose, p < 0.05 vs. predrug. B) SNP Dose-
response curves across varying levels of acidosis. *main effect of dose, p < 0.05 vs. 
predrug. Data are presented as mean ± SE. 
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Figure 13. Changes in receptor-mediated function unaccounted for by changes in 
vascular smooth muscle function. Data are presented as mean ± SE. 
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Using a novel approach of obtaining and studying human skeletal muscle feed 
arteries in vitro, these studies aimed to determine if physical factors, such as heat and 
acidosis, at physiological levels achievable during exercise could modulate the response 
to the α1-adrenergic sympathomimetic, phenylephrine. The results from these studies 
revealed that factors normally released in significant quantities as a consequence of 
skeletal muscle metabolism (e.g. heat and hydrogen ions) or their downstream effectors 
(e.g. NO) are certainly capable of inducing a sympatholytic effect upon the α1-receptors, 
a primary target for norepinephrine, the neurotransmitter released as a result of both 
feedback and feed-forward mechanisms in response to exercise. The consequence of the 
reductions in α1-mediated vasocontraction observed in these studies would likely prevent 
increases in vascular resistance in response to norepinephrine released as a consequence 
of exercise-induced increases in muscle sympathetic nerve activity. In addition, reduced 
vascular responsiveness associated with metabolic perturbation has implications for the 
maintenance of mean arterial pressure in emergency or pathological situations, such as 
hyperthermia, or metabolic acidosis. 
 In the first study, we aimed to determine the effect of temperature on vascular 
responsiveness. To achieve this, we performed in vitro vessel wire myography 
experiments in response to cooling (35°C) and heating (39°C) within a physiological 
range. The major mechanism involved in the acute regulation of vascular tone and blood 
flow is the sympathetic nervous system; thus, we sought to determine if heating or 
cooling would alter the response to phenylephrine, an α1-adrenergic agonist with a 
relatively greater affinity for the α1-receptor than the α2-adrenergic receptor. We chose to 
focus on the α1-adrenergic receptor, because prior work has demonstrated a graded 
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sympatholytic effect of exercise on α1-receptor responsiveness, whereas the α2-receptors 
appear to be  lysed immediately, upon the commencement of exercise even with unloaded 
knee extensor exercise (4). Recognizing the potential for temperature to alter inherent 
smooth muscle function, we utilized potassium chloride (KCl) to determine if 
temperature would, in fact, alter smooth muscle function. If so, the responses to 
phenylephrine could have been normalized to the temperature-induced alteration in basal 
smooth muscle function. Additionally, given the lack of reference values for vascular 
reactivity of these human skeletal muscle feed arteries, and to rule out individual vascular 
dysfunction as a mediator in the response to temperature, we performed dose-response 
curves to characterize receptor- and nonreceptor-mediated vasocontraction using PE and 
KCl, respectively. To characterize the endothelium-dependent and endothelium-
independent vasorelaxant function of these vessels, dose-response curves were performed 
for acetylcholine (ACh) and sodium nitroprusside (SNP), respectively.  
 The dose response curves for PE, KCl, ACh, and SNP revealed that these vessels 
are capable of producing significant force in response to PE and KCl, and the 
vasodilators ACh and SNP induced appropriate levels of vasorelaxation, indicating the 
vessels employed in these studies were functional and had an intact endothelium. We 
found that both heating (39°C) and cooling (39°C) reduced the vasocontractile response 
to a single dose or across a spectrum of doses of PE, performed either in a cross-sectional 
or longitudinal manner. Interestingly, the response to a single dose of KCl remained 
intact despite the temperature perturbation. These results indicate that the attenuating 
effect of perturbing temperature are not the result of the smooth muscle, per se, and other 
factors are instigating the reduction in the α1-adrenergic receptor response observed with 
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the changes in temperature. Regardless of a specific mechanism, it appears temperature 
could be a potent regulator of vascular tone in human skeletal muscle feed arteries, a 
vessel that is considered to be a point of regulation of skeletal muscle blood flow (3).  
 To ascertain the mechanism behind the attenuating effect of heating upon skeletal 
muscle feed artery response to the α1-receptor agonist, dose-response curves were again 
performed in normothermic (37 °C) and hyperthermic (39 °C) conditions, but now in the 
absence and presence of the endothelial nitric oxide synthase (eNOS) inhibitor, L-
NMMA. We hypothesized that heating would increase the enzyme kinetics of eNOS, and 
increase NO bioavailability opposing the PE-induced increase in vascular tone. Thus, 
effective blockade of eNOS would partially restore the contractile effects of PE towards 
that observed at 37°C. Employing the same methodology as the first study, human 
skeletal muscle feed arteries were again obtained and studied using isometric force 
technique. To rule out potential vascular dysfunction dose-responses for PE, KCl, ACh, 
and SNP were performed to characterize the receptor- and nonreceptor-mediated 
vasocontraction and vasorelaxation, respectively. Additionally, we exposed a subset of 
arteries to normo- and hyperthermic conditions, to determine if the effect of heating was 
due to an upregulation of eNOS protein or downregulation of α1-adrenergic receptor 
protein, using standard molecular techniques.  
 In agreement with the first study, we found that temperature exerted an 
attenuating effect upon α1-mediated vasocontraction. Remarkably, blockade of eNOS 
during heating to 39°C restored the vasocontractile response to PE to that of the 
normothermic condition. Blockade of eNOS also tended to increase the response to PE at 
37°C; however, the percent increase was not significant as compared to the hyperthermic 
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condition. Curve analysis revealed heating significantly reduced the sensitivity to the α1-
agonist, PE. In support of these findings, the western blot analyses revealed an 
upregulation of eNOS, but no change in α1-adrenergic receptor protein. Taken together, 
these findings suggest that heating increases the bioavailability of NO, which acts to 
oppose the effects of α1-mediated vasocontraction. These data again reveal the potential 
for temperature to be an important regulator of blood flow, via reduced α1-receptor 
mediated vasocontraction, but also highlights the role for vasodilators (e.g. NO) in 
modulating vasoconstrictor responsiveness. In essence, functional sympatholysis may not 
be a result of reduced sympathetic efficacy as in the traditional sense, but the 
consequence of increased vasodilatory opposition to such sympathetic stimuli. 
 The third study investigated the role of increased hydrogen ion concentration and 
the parallel reductions in pH on vascular reactivity. Again, utilizing the in vitro approach, 
which allowed the strict control of the metabolic milieu, we were able to create graded 
levels of acidosis, in the absence of other metabolic disturbances. Again, human skeletal 
muscle feed arteries were obtained, and studied using the isometric tension technique. We 
performed dose-response curves for PE, KCl, ACh, and SNP to determine receptor- and 
nonreceptor-mediated vasocontraction and vasorelaxation characteristics, respectively. 
Each of these dose-response curves were performed at normal pH (7.4), and across 
increasing levels of acidosis, pH 7.1, pH 6.8, and pH 6.5. These pH values were chosen 
because these represent levels attainable in the skeletal muscle (1) and interstitial spaces 
(2) during graded exercise. We hypothesized that reductions in pH, within a physiological 
range, would be paralleled by reductions in α1-receptor-mediated vasocontraction. 
However, we also expected that the reductions in vasocontraction could be, at least in 
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part, due to altered smooth muscle function. Additionally, we hypothesized that the 
enhanced vasorelaxation would contribute to the suppressant effect of acidosis and thus 
the vasorelaxation response to ACh and SNP will be enhanced with acidosis. 
 We determined that increasing levels of acidosis resulted in parallel reductions in 
PE-induced vasocontraction which are partially explained by a concomitant reduction in 
KCl-mediated vasocontraction. However, it appears that the suppressant effect of acidosis 
on α1-adrenergic receptor function cannot be fully explained by reduced inherent smooth 
muscle function, as assessed by KCl. With the goal of determining if altered 
vasorelaxation contributed to the observed reduction in α1-receptor mediated 
vasocontraction, ACh and SNP dose-response curves were constructed at each pH. 
Interestingly, in the face of acidosis, there was no difference across ACh and SNP dose or 
maximal dilation. However, the curve analyses revealed that increasing acidosis resulted 
in significant increases in the sensitivity to the endothelial dependent dilator ACh, as 
assessed by EC50 and log EC50 analyses. Together, these results suggest that acidosis, 
such as that achievable during exercise, is capable of suppressing vasoconstrictor 
responsiveness which was likely the summation of reduced smooth muscle, α1-adrenergic 
receptor function, and maintained vasorelaxation capacity.  
The attainment of human skeletal muscle feed arteries, is both novel and germane 
to understanding how factors such as temperature or acidosis could alter sympathetically 
mediated vasocontraction, via the α1-adrenergic receptor, and subsequently the regulation 
of skeletal muscle blood flow in humans. Collectively, these results indicate that local 
metabolic factors, such as heat and H+, are capable of inducing a sympatholytic effect on 
human skeletal muscle feed arteries, and therefore likely contribute to exercise 
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hyperemia. These studies are the first to characterize human skeletal muscle feed artery 
function, and determine if these arteries are “metabolically-sensitive.” We also 
demonstrate that the α1-adrenergic receptor is not immune to metabolic-inhibition, as 
traditionally demonstrated in animal models. These findings may also have clinical 
implications for understanding factors that contribute to hypotension in emergent and 
pathological situations, such as heat stroke or metabolic acidosis. In summary, we 
conclude that metabolic by-products such as heat and hydrogen ions alter vascular 
reactivity in humans, which may have broad application for the understanding of human 
physiology. 
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